Home Health Limited is building Lagos's most trusted home-based healthcare platform, starting with premium human care and scaling toward a technology layer that turns every care interaction into actionable health intelligence.
Three converging forces are creating an urgent, underserved demand for structured home-based healthcare in Nigeria, and across Africa.
Nigeria's population aged 65 and above is projected to grow from 6 million in 2020 to 16 million by 2050. The demand for aging-in-place solutions is not a trend; it is a demographic inevitability. Africa is the world's fastest-growing aging population with the least infrastructure to support it.
Traditional hospital systems in Nigeria are over-leveraged. With only 20 healthcare workers per 10,000 people, less than half the WHO minimum. The shift from "hospital to home" is no longer a preference. It is a structural economic necessity that no scaled private operator has yet addressed.
While banking, logistics, and retail have been transformed by data and AI, home health in Nigeria remains almost entirely analog. The caregiver who visits a client's home generates zero structured data. This gap is HHL's long-term moat: we are building the data layer from the ground up, starting with every care interaction.
Nigeria's elderly population is on a trajectory that will create one of the world's most significant care deficits. The shift from extended family systems to nuclear families has removed the informal caregiving safety net. Skilled healthcare workers continue to emigrate. And no national aging policy or elderly care framework exists.
This is where Home Health Limited operates: not as a charity filling a gap, but as a premium private platform building the infrastructure that affluent Nigerian families, diaspora members, and eventually insurers and employers will pay for.
| Year | Elderly (65+) | HCW per 10,000 | Care Gap |
|---|---|---|---|
| 1980 | 2 million | 25 | |
| 2000 | 3.5 million | 23 | |
| 2020 | 6 million | 20 | |
| 2030 | 9 million | 18 (proj.) | |
| 2050 | 16 million | 16 (proj.) | |
| 2100 | 74 million | 15 (proj.) |
Nigeria's care gap is not a future problem. It is an accelerating present reality with no structured private solution at scale.
Nigeria has 55% fewer healthcare workers than the WHO minimum. The deficit widens as emigration continues.
Home health sits at a unique intersection: consistent, longitudinal access to patients in their natural environment. No other healthcare setting generates this kind of continuous, contextual data. HHL is designed from the ground up to capture it, analyse it, and act on it.
Vitals, mobility patterns, medication adherence, clinical observations, and caregiver notes. Logged consistently across every visit, every patient, every day.
Longitudinal data is analysed to surface deviations from each patient's personal baseline. Subtle shifts in vitals, sleep, appetite, or cognition become early warning signals, not post-event discoveries.
Flagged anomalies trigger structured alerts to clinical leads and attending physicians. Families receive real-time updates. Doctors receive clinically useful summaries, not raw data dumps.
A hospital sees a patient for hours. HHL sees a patient for months. That continuity, structured and analysed at scale, becomes a proprietary health intelligence layer that is extraordinarily difficult to replicate.
Early intervention, not emergency response
Catching a patient's declining kidney function at week three of care rather than in an A&E waiting room changes outcomes and cuts costs.
Physician-grade summaries, not caregiver notes
Structured data formatted for clinical decision-making. Doctors get what they actually need to adjust treatment in between hospital visits.
A dataset that compounds over time
The more patients we serve, the more accurate our anomaly models become. Scale creates a self-reinforcing intelligence advantage.
We begin with direct-to-consumer premium care and expand into B2B and platform revenue as we scale.
Tiered care packages sold directly to Lagos families: Foundation Care (drop-in visits), Enhanced Support (12-hour shifts), and Complete Partnership (24/7 live-in). Pricing follows a home assessment and personal consultation. No fixed published rates; every package is tailored.
Primary revenue engine through Phase 1 and 2.
Working with private hospitals on post-acute discharge care, where HHL becomes the preferred home care partner for patients leaving surgical or specialist wards. Longer term, partnering with private insurers to reduce long-term claim payouts through preventative home monitoring.
Referral fees and per-patient contracts.
Corporate care packages allowing companies to offer home-based elderly care for employees' parents as a benefit, a growing talent retention tool in Nigeria's premium employer market. Positions HHL within HR benefit stacks alongside private health insurance.
Recurring subscription revenue per corporate client.
Once our care operating model and predictive monitoring layer are proven at scale in Lagos, licensing the platform to independent home care providers nationally and across West Africa, transforming HHL from a service business into the infrastructure layer for the sector.
High-margin recurring SaaS revenue at scale.
Establishing HHL as Lagos's most trusted premium home healthcare provider. Refining the AI-integrated care model (capture, predict, act) with real patient data. Building the clinical and operational playbook that underpins everything that follows.
Expanding into new cities and launching B2B pilot programmes with major insurers, hospitals, and pharmacy chains. The data infrastructure built in Phase 1 becomes the foundation for institutional partnerships and managed care contracts.
Licensing the HHL monitoring platform to independent care providers nationally and globally. The intelligence layer becomes a standalone SaaS product that generates recurring high-margin revenue independent of direct care delivery.
Every care interaction is a data point. Over time, those data points become a continuous health intelligence layer: giving families visibility, giving physicians early signals, and giving HHL a defensible asset that scales beyond the number of caregivers we can place.
As the platform matures, passive IoT data collection removes the dependency on manual caregiver logging. Smart wearables, environmental sensors, and connected health devices feed a continuous stream of patient data into the HHL intelligence layer - enabling anomaly detection that operates around the clock, not just during care visits.
The AI layer learns each patient's personal baseline - their normal heart rate range, typical sleep patterns, usual mobility levels - and surfaces deviations before they become symptoms a caregiver would notice. This is the shift from reactive care to predictive care.
Continuous Vitals Monitoring
Wearable pulse oximeters, BP cuffs, and glucose monitors streaming data in real time to the HHL platform
AI Anomaly Detection
Machine learning models trained on longitudinal patient data flag deviations from personal baselines - not population averages
Smart Environment Sensing
Motion sensors, fall detection, sleep tracking, and room environment monitoring for patients who cannot self-report
Predictive Intervention Engine
Correlates multi-signal data to predict deterioration windows - enabling clinical intervention days before a crisis, not hours after
HHL is built around a triple bottom line. Strong financial returns and measurable social impact are not in tension here; they are the same thing.
Reducing the multi-billion naira cost of preventable geriatric, pediatric, and natal hospital readmissions. Every avoided hospital event is a direct cost saving for families, insurers, and the public health system. Home-based care at scale is one of the most economically efficient healthcare interventions available.
Improving Quality Adjusted Life Years (QALYs) for clients by enabling earlier detection, consistent medication management, and continuous clinical oversight. These are outcomes that are measurable, documentable, and increasingly valued by both institutional investors and insurance partners.
The home healthcare market in Nigeria is large and underserved. Winning it requires more than intention. It requires the right structure, the right team, and the right timing.
HHL does not own hospitals or build facilities. We deploy vetted caregivers and nurses into family homes, supervised by a clinical layer. This means faster scale, lower capital requirements, and unit economics that improve as volume grows.
In a category where trust is everything, HHL is investing in brand from day one. Premium positioning, clinical credibility, and family-facing communication standards create defensibility that price-competing operators cannot replicate easily.
Our family dashboard, clinical oversight tools, and AI-assisted monitoring are not add-ons. They are the delivery mechanism. As data accumulates, the platform becomes more valuable, more predictive, and harder to replicate.
Nigeria has one of the world's largest diaspora communities, many of whom are actively managing care decisions for parents at home. HHL is built to serve this segment, creating a recurring international revenue channel that most local operators ignore.
Many home care operators begin informal and attempt to add clinical credibility later. HHL launches with an RN Clinical Lead, structured governance, and documented escalation protocols. This creates regulatory readiness and insurance partnership potential from the start.
Discharge referrals from hospitals, clinics, and specialist physicians represent the highest-quality, lowest-cost lead generation in the home care industry. HHL's clinical credibility and partner programme are designed to capture this channel at scale.
We are seeking visionary investors, strategic partners, and institutional supporters who understand that the window to establish a category-defining brand in Nigeria's home care market is open now, and will not remain open indefinitely.
IMPORTANT DISCLAIMER. This page is intended for prospective investors and strategic partners only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. The information on this page is provided for informational purposes only and should not be relied upon as the basis for any investment decision. Forward-looking statements reflect current intentions, plans, and expectations only. Actual results may differ materially. Home Health Limited is a pre-revenue, pre-launch company. Any investment involves significant risk, including the potential loss of the entire amount invested. Prospective investors should seek independent legal, financial, and regulatory advice before making any investment decision. This page has not been approved by any regulatory authority.